نتایج جستجو برای: fgfr3

تعداد نتایج: 1106  

Journal: :Blood 2005
Tomoya Maeda Fumiharu Yagasaki Maho Ishikawa Naoki Takahashi Masami Bessho

We previously reported a novel fusion between TEL and FGFR3 in a patient with peripheral T-cell lymphoma with t(4; 12)(p16;p13). Disease in this patient subsequently progressed to acute myelogenous leukemia (AML) with the same translocation. Sequence analysis of TEL-FGFR3 fusion transcripts suggested that these diseases originated from the same multipotent stem cell. To determine the transformi...

Journal: :Molecular biology of the cell 2001
K C Hart S C Robertson D J Donoghue

Fibroblast growth factor receptor 3 (FGFR3) mutations are frequently involved in human developmental disorders and cancer. Activation of FGFR3, through mutation or ligand stimulation, results in autophosphorylation of multiple tyrosine residues within the intracellular domain. To assess the importance of the six conserved tyrosine residues within the intracellular domain of FGFR3 for signaling,...

Journal: :Structure 2013
Eduard V Bocharov Dmitry M Lesovoy Sergey A Goncharuk Marina V Goncharuk Kalina Hristova Alexander S Arseniev

Fibroblast growth factor receptor 3 (FGFR3) transduces biochemical signals via lateral dimerization in the plasma membrane, and plays an important role in human development and disease. Eight different pathogenic mutations, implicated in cancers and growth disorders, have been identified in the FGFR3 transmembrane segment. Here, we describe the dimerization of the FGFR3 transmembrane domain in ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Anna Luisa Di Stefano Alessandra Fucci Veronique Frattini Marianne Labussiere Karima Mokhtari Pietro Zoppoli Yannick Marie Aurelie Bruno Blandine Boisselier Marine Giry Julien Savatovsky Mehdi Touat Hayat Belaid Aurelie Kamoun Ahmed Idbaih Caroline Houillier Feng R Luo Jean-Charles Soria Josep Tabernero Marica Eoli Rosina Paterra Stephen Yip Kevin Petrecca Jennifer A Chan Gaetano Finocchiaro Anna Lasorella Marc Sanson Antonio Iavarone

PURPOSE Oncogenic fusions consisting of fibroblast growth factor receptor (FGFR) and TACC are present in a subgroup of glioblastoma (GBM) and other human cancers and have been proposed as new therapeutic targets. We analyzed frequency and molecular features of FGFR-TACC fusions and explored the therapeutic efficacy of inhibiting FGFR kinase in GBM and grade II and III glioma. EXPERIMENTAL DES...

Journal: :Mechanisms of Development 2009
Yijing Chen Tom Pratt David Price

Structural changes caused by altered Fibroblast Growth Factor (FGF) signaling during embryonic development have been shown to influence cortical function and animal behavior. FGFs are known to control patterning and neurogenesis, the initial two key events that define forebrain structures. We hypothesized that one of the four high-affinity FGF receptors, Fgfr3, may regulate rostrocaudal forebra...

2011
Imran Ahmad Lukram Babloo Singh Mona Foth Carol-Ann Morris Makoto Mark Taketo Xue-Ru Wu Hing Y. Leung Owen J. Sansom Tomoko Iwata

The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a 'driver' of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using Cre-loxP recombination driven by the uroplakin II promoter. The introduction of the Fgfr3 mutations resul...

Journal: :Blood 2005
Suzanne Trudel Zhi Hua Li Ellen Wei Marion Wiesmann Hong Chang Christine Chen Donna Reece Carla Heise A Keith Stewart

The t(4;14) translocation that occurs uniquely in a subset (15%) of patients with multiple myeloma (MM) results in the ectopic expression of the receptor tyrosine kinase (RTK), fibroblast growth factor receptor 3 (FGFR3). Inhibition of activated FGFR3 in MM cells induces apoptosis, validating FGFR3 as a therapeutic target in t(4;14) MM and encouraging the clinical development of FGFR3 inhibitor...

2012
Xiangnan Du Qian-Rena Wang Emily Chan Mark Merchant Jinfeng Liu Dorothy French Avi Ashkenazi Jing Qing

Fibroblast growth factor receptor 3 (FGFR3) belongs to a family of receptor tyrosine kinases that control cell proliferation, differentiation, and survival. Aberrant activation of FGFR3 via overexpression or mutation is a frequent feature of bladder cancer; however, its molecular and cellular consequences and functional relevance to carcinogenesis are not well understood. Through transcriptiona...

2017
Yangli Xie Fengtao Luo Wei Xu Zuqiang Wang Xianding Sun Meng Xu Junlan Huang Dali Zhang Qiaoyan Tan Bo Chen Wanling Jiang Xiaolan Du Lin Chen

Bone fracture healing is processed through multiple biological stages that partly recapitulates the skeletal development process. FGFR3 is a negative regulator of chondrogenesis during embryonic stage and plays an important role in both chondrogenesis and osteogenesis. We have investigated the role of FGFR3 in fracture healing using unstabilized fracture model and found that gain-of-function mu...

2013
Masaki Matsushita Hiroshi Kitoh Bisei Ohkawara Kenichi Mishima Hiroshi Kaneko Mikako Ito Akio Masuda Naoki Ishiguro Kinji Ohno

Achondroplasia (ACH) is one of the most common skeletal dysplasias with short stature caused by gain-of-function mutations in FGFR3 encoding the fibroblast growth factor receptor 3. We used the drug repositioning strategy to identify an FDA-approved drug that suppresses abnormally activated FGFR3 signaling in ACH. We found that meclozine, an anti-histamine drug that has long been used for motio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید